Citations

Clear

13603 citation(s) found for "_, _".

Lazarus Sign, a Misnomer to an Anatomical Spinal Reflex
Costantini, Sabrina, Apaydın, Nihal, Loukas, Marios , Apaydin, Nihal , Loukas, Marios , Iwanaga, Joe , Totlis, Trifon

Mayo Clinic

Clinical Anatomy | April 17, 2025 | Volume: 39 | Issue: 4 | Pages: 430-435

10.1002/ca.24279 | PMID 40245303 Get It

ABSTRACT The Lazarus sign is a well‐documented spinal reflex observed in brain‐dead patients, characterized by involuntary upper limb movements that can resemble voluntary gestures. Initially described during the 1980s, this phenomenon has contributed to ongoing discussions about the physiological basis of spinal reflexes and their role in assessing brain death. The Lazarus sign was once considered a diagnostic challenge, but recent research reports confirm that it originates solely from the spinal cord, independent of brainstem or cortical activity. However, recent studies also suggest that spinal reflexes in brain‐dead patients, including the Lazarus sign, can be more variable than previously thought, occurring in multiple limb regions beyond the upper limbs. Prolonged survival in brain‐dead patients exhibiting the Lazarus sign has also raised new questions about its physiological significance. Its recognition has helped refine brain death criteria, ensuring accurate diagnoses and minimizing misinterpretations in critical care and organ donation settings. PubMed‐indexed studies and backward citations were reviewed. Studies were included if they explicitly described spinal reflexes in brain‐dead patients, examined neurophysiological mechanisms, or provided clinical observations on the Lazarus sign. Exclusion criteria included studies focusing solely on brainstem activity without considering spinal reflexes or case reports lacking detailed methodology. These investigations explored the prevalence, neurophysiological mechanisms, and clinical significance of the Lazarus sign. Research highlights its variable presentation, its occurrence in up to 40% of brain‐dead patients, and its potential to be misunderstood by families and healthcare providers. The sign does not indicate residual brain function, but it reinforces the need for clear communication in end‐of‐life care. Future research should focus on standardizing diagnostic protocols, educating clinicians, and addressing ethical concerns. Integrating this knowledge into brain death assessments will enhance clinical decision‐making and patient management.
Abstract P1121: Late-Life Physical Activity and Brain Imaging and Plasma Biomarkers of Alzheimer’s Disease Pathology, Cerebrovascular Disease, and Neurodegeneration: The Atherosclerosis Risk in Communities Neurocognitive (ARIC-NCS) Study
Barbee, Jenna M., Gu, Zhengyi, Chen, Jinyu , Munson, Alexandra , Kartheiser, Katherine, Hughes, Timothy M. , Windham, B. Gwen , Sharrett, A. Richey , Coresh, Joe, Palta, Priya, Pike, James Russell , Gabriel, Kelley Pettee , Knopman, David S. , Walker, Keenan A. , Gottesman, Rebecca F. , Sullivan, Kevin , Lutsey, Pamela L. , Thyagarajan, Bharat , Mosley, Thomas H.

Mayo Clinic

Circulation | April 17, 2025 | Volume: 151 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.151.suppl_1.p1121 Get It

Introduction: Physical activity (PA) has been identified as a protective factor for dementia, but the mechanisms linking PA to brain health are unclear. To elucidate potential pathways linking PA to brain health, we tested the hypothesis that higher levels of late-life PA are associated with a lower burden of Alzheimer’s disease (AD) pathology, cerebrovascular disease, and neurodegeneration measured through brain imaging and plasma biomarkers. Methods: ARIC-NCS participants without dementia in 2011-13 and with measures of PA, 3T brain magnetic resonance imaging (MRI), and stored plasma samples were examined (n=1,771; mean age: 76.5 years; 40.5% male; 27.6% Black). Participants were classified as meeting or not meeting 2018 aerobic PA guidelines based on a standardized interviewer-administered questionnaire. MRI biomarkers included white matter hyperintensity (WMH) volume (cm 3 ), total brain volume (TBV) (cm 3 ), and cortical thickness (CT) (mm). Plasma biomarkers of the ratio of amyloid beta 42 to 40 (Aβ42/Aβ40), phosphorylated Tau-181 (p-Tau181), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were measured using Quanterix Simoa immunoassays. All biomarkers were standardized to measures in 2011-13 to facilitate comparisons. Covariate-adjusted linear regression models estimated cross-sectional associations of PA with MRI or plasma biomarkers. Covariate-adjusted linear mixed effects models quantified associations of PA with the 5-year rate of change in a subset of participants with MRI (n=669) or plasma (n=651) biomarkers at both baseline and follow-up from 2011-19 (median follow-up: 5.4 years). Results: Meeting versus not meeting aerobic PA guidelines was cross-sectionally associated with lower volumes of WMH (β = -0.16, 95% CI: -0.25, -0.07), higher TBV (β = 0.09; 95% CI: 0.05, 0.13), and lower plasma NfL (β = -0.102, 95% CI: -0.184, -0.021) ( Figure ). Late-life PA was not associated with 5-year rates of change in MRI or plasma biomarkers. Conclusions: Late-life PA was cross-sectionally associated with less neurodegeneration and cerebrovascular disease. Associations with 5-year changes in imaging and plasma biomarkers of AD pathology, cerebrovascular disease, or neurodegeneration were not statistically supported. Longitudinal biomarker studies with wearable devices that quantify other daily intensity-based movement metrics (e.g., light PA) and larger sample sizes are needed to further examine mechanisms linking PA to brain health.
Abstract P3174: The Benefits of Probiotic Administration in Stroke Risk, Stroke-Related Gastrointestinal Complications, and Intestinal Flora Dysbiosis: A Meta-Meta-Analysis
Devabhaktuni, Sarayu, Khan, Aishah, Sudhir, Gaurav , Gupta, Devansh , Mukesh, Sindu, Bhriguvanshi, Arpita, Baskar, Aakash , Arumaithurai, Kogulavadanan , Arora, Rohan , Patel, Urvish , Khan, Aishah, Parvataneni, Tarun

Mayo Clinic

Circulation | April 17, 2025 | Volume: 151 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.151.suppl_1.p3174 Get It

Introduction: Stroke is the second largest cause of death and third leading cause of disability worldwide. Some high-income countries have one in five lifetime cases and one in two in low-income countries. Due to the high stroke burden and aging population, better preventive and treatment approaches are needed. Recent research shows that stroke patients have a different gut microbiota than healthy people, suggesting a relationship between dysbiosis and stroke incidence and prognosis. Probiotics may improve stroke outcomes by strengthening the intestinal barrier and reducing inflammation. Hypothesis: Our study seeks to evaluate the potential benefits of probiotic supplementation in reducing the risk of ischemic stroke in healthy individuals as well as its impact on the prognosis of stroke patients, specifically in reducing gastrointestinal complications and improving gut microbiota balance (reduce dysbiosis). Methods: We conducted an umbrella meta-analysis of meta-analyses published in the last 10 years using PRISMA guidelines in PubMed. Using RevMan 5.4, we performed an inverse variance random effects model to calculate log (odds ratio) and converted it to pooled OR and 95% confidence interval to obtain a forest plot keeping alpha criteria 0.05. Heterogeneity and risk of bias assessment (by Newcastle-Ottawa Scale) were assessed. Results: While probiotic supplementation in healthy individuals did not significantly decrease the risk of ischemic stroke (OR 0.87 [95%CI 0.75-1.01]), it showed notable benefits in stroke patients. These positive effects included a substantial reduction in the odds of specific GI complications (constipation, diarrhea, gastric retention, esophageal reflux, vomiting, stress ulcers, and gastrointestinal bleeding) by 62% (0.38, 0.29-0.51), non-specific GI complications by 72% (0.28, 0.24-0.34), infection by 73% (0.27, 0.21-0.33) and a significant improvement in gut flora balance, reducing the odds of dysbiosis by 79% (0.21, 0.12-0.36). (p<0.00001) The inter-study heterogeneity was 91% with (p<0.00001, Chi 2 =128.76), a moderate risk of bias. Conclusion: Our umbrella meta-analysis highlights the potential benefits of probiotic supplementation in stroke patients, particularly in mitigating stroke-related GI complications and alleviating intestinal flora dysbiosis. These findings underscore the crucial role of gut-brain interactions in stroke and suggest that probiotics may serve as a promising component of stroke management.
Abstract P1020: Relationship Between CHA 2 DS 2 -VASc, Health Literacy, and Atrial Fibrillation Knowledge
Nayak, Tanvi , Kansal, Preeti , Jeewa, Shiza, Pershing, Mandy L. , Fagerlin, Angie, Wu, Chaorong , Group, STEP-UP AF Writing, Nayak, Tanvi , Cameron, Kenzie A. , Ozanne, Elissa M. , Barnes, Geoffrey D. , Cavanaugh, Kerri L. , Jackson, Elizabeth A. , Montori, Víctor M. , Passman, Rod , Group, STEP-UP AF Writing

Mayo Clinic

Circulation | April 17, 2025 | Volume: 151 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.151.suppl_1.p1020 Get It

Introduction: It is unknown how comorbid diagnoses affect patients’ disease-specific knowledge or how patients’ health literacy or numeracy affects this relationship. In patients with atrial fibrillation (AF), comorbidities can be quantified by the CHA 2 DS 2 -VASc score. We explore the association of AF/stroke knowledge with CHA 2 DS 2 -VASc score, health literacy, and numeracy for usual care participants in the multi-center Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation (RED-AF) trial evaluating decision aids to initiate (initiation cohort) or continue (monitor cohort) oral anticoagulation (OAC) in AF patients. Methods: This study was conducted at six academic medical centers in the United States. Participants were aged ≥18, diagnosed with non-valvular AF, and at risk for stroke (CHA 2 DS 2 -VASc ≥1 for men, ≥2 for women). Patient demographics were obtained via questionnaires after a baseline clinical encounter; knowledge was evaluated by patient responses to 7 questions about OAC and AF. Health literacy was measured by a validated self-reported screening tool; numeracy by a validated subjective numeracy scale; CHA 2 DS 2 -VASc was calculated from medical records. We applied generalized estimating equations for a binomial outcome to jointly relate patient knowledge to CHA 2 DS 2 -VASc score, health literacy and numeracy, controlling for 5 additional patient factors and accounting for clustering by clinician. Results: We report on 306 patients randomized to the usual care group across six participating sites. Average age 68.7 9, 61.6% male, mean CHA 2 DS 2 -VASc 2 1.5. Patient knowledge was independently associated with numeracy (5% higher odds of correct response per 1 unit increase in numeracy, 95% CI 0-10%, p=0.05) and membership in the monitor cohort (40% odds of correct response, 4-89%, p=0.03) but not health literacy or increased stroke risk. Conclusion: In the RED-AF study , although health literacy and increasing stroke risk were not independently associated with patient knowledge about AF, numeracy had a minimal positive association. Those already on OAC had greater disease knowledge than patients newly starting OAC. These results suggest a need to broadly increase patient education regardless of baseline comorbidity burden and degree of health literacy. Future studies should be performed to better understand other factors that drive patient knowledge regarding AF and stroke.
Physical Activity, Sleep, and Quality of Life in Pulmonary Arterial Hypertension: Novel Insights From Wearable Devices
Hughes, Andrew , Lindsey, Alisha, Annis, Jeffrey , Burke, Kelly, Master, Hiral , Silverman-Lloyd, Luke G , Garry, Jonah , Hassoun, Paul M. , Larive, Brett , Hill, Nicholas S. , Erzurum, Serpil C. , Beck, Gerald J. , Hughes, Andrew M , Garry, Jonah D , Hemnes, Anna , Lindsey, Alisha, Blaha, Michael Joseph , Rosenzweig, Erika B. , Frantz, Robert P. , Hassoun, Paul M. , Horn, Evelyn M. , Leopold, Jane A. , Rischard, Franz , Hemnes, Anna R. , Brittain, Evan L

Mayo Clinic

Pulmonary Circulation | April 17, 2025 | Volume: 15 | Issue: 2 | Pages: No page available

10.1002/pul2.70069 | PMID 40248215 Get It

ABSTRACT Reduced functional capacity and poor sleep quality are common in pulmonary arterial hypertension (PAH). Wearable devices are an emerging, user‐friendly tool to capture activity and sleep information. We aimed to determine whether Fitbit‐derived activity and sleep trends provide clinically meaningful information in patients with PAH. Our prospective observational study recruited patients with PAH from across the United States using remote enrollment strategies and in‐person efforts. Participants wore a Fitbit device for 12 weeks at baseline and a subgroup with 1‐year follow‐up. A matched control cohort was generated from the All of Us Research Program and we evaluated changes in patients with PAH compared to matched controls. Among 110 patients with baseline monitoring, average daily steps correlated with 6MWD ( r = 0.61, p < 0.001) and percent rapid eye movement (REM) sleep ( r = 0.28, p = 0.008). In 44 PAH participants who completed baseline and 1‐year monitoring, there was a group‐time interaction for percent light sleep ( p = 0.024) and percent REM sleep ( p = 0.034), which demonstrated that sleep quality worsened in patients with PAH over 1 year compared to matched controls. Average daily steps decreased in patients with PAH from 5200 [IQR 3212–7458] at baseline to 4651 [IQR 2912–6827] at 1 year ( p = 0.008). In conclusion, our study demonstrated the potential clinical value of wearable devices by showing that activity and sleep quality are reduced in PAH compared to matched controls and these measures decline over time. Future studies should investigate if monitoring these health behaviors detects early functional decline and whether targeted interventions may improve outcomes.
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations
Kittai, Adam S. , Al‐Sawaf, Othman , Benjamini, Ohad , Danilov, Alexey V. , Eichhorst, Barbara , Eyre, Toby A. , Frustaci, Anna Maria , Hallek, Michael , Hampel, Paul J. , Herishanu, Yair, Kater, Arnon P. , King, Rebecca L. , Owen, Carolyn , Rossi, Davide, Wierda, William G. , Gaïdano, Gianluca , Woyach, Jennifer A. , Eyre, Toby A , Frustaci, Anna Maria , Hampel, Paul J , Hicks, Rodney J , Kater, Arnon P , Parry, Erin M , Siddiqi, Tanya , Thompson, Philip A , Gaidano, Gianluca , Woyach, Jennifer A , Ghia, Paolo , Marchetti, Monia , Davids, Matthew S. , Herishanu, Yair , Martin-Subero, Jose Ignacio , Parry, Erin M. , Ponzoni, Maurilio , Rossi, Davide, Siddiqi, Tanya , Stilgenbauer, Stephan , Tam, Constantine S. , Hacken, Elisa ten , Wierda, William G. , Ghia, Paolo

Mayo Clinic

Blood | April 16, 2025 | Volume: 146 | Issue: 3 | Pages: 291-303

10.1182/blood.2024028064 | PMID 40239121 Get It

Abstract Richter transformation (RT) is defined as an aggressive lymphoma emerging in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Despite novel therapeutics developed in CLL, RT is associated with poor outcomes. In light of recent progress regarding the diagnostic procedures and therapeutic concepts of RT, an international group of experts, under the coordination of the European Research Initiative on CLL, has developed consensus recommendations for clinical procedures and future research on this disease. Patients with RT typically present with a rapid clinical decline, worsening B-symptoms, elevated lactate dehydrogenase, and/or rapidly enlarging lymphadenopathy. Workup should include a positron emission tomography–computed tomography scan for patients with suspected RT. An excisional biopsy should be taken from an accessible lesion, preferably with the highest fluorodeoxyglucose avidity, and analyzed for the presence of aggressive lymphoma. The molecular relationship to the original CLL clone(s) should be defined. Because no effective standard treatment for RT exists, patients should be treated in a clinical trial. Response of both RT and CLL should be assessed at an early time point, and survival end points should be prioritized in trial design. We hope that these recommendations can help to harmonize clinical and translational research and improve outcomes for patients with RT.
Assessing fall risk in multiple sclerosis using patient-reported outcomes and wearable gait metrics
Banks, Samantha A. , Mandrekar, Jay , Jahanian, Omid , Ali, Farwa , Sagen, Jessica, Spence, Robert, Gossman, Kellie A, Kantarci, Orhun H. , Pittock, Sean J. , Pittock, S J , Jahanian, Omid , Pittock, Sean J , Baker, Matthew R , Flanagan, E P , Keegan, B Mark , Tobin, W Oliver , Banks, Samantha , Howe, Charles L. , Spence, Robert, Baker, Matthew , Flanagan, Eoin P. , Keegan, B. Mark , Tobin, W. Oliver

Mayo Clinic

Multiple Sclerosis Journal – Experimental, Translational and Clinical | April 16, 2025 | Volume: 11 | Issue: 2 | Pages: No page available

10.1177/20552173251329825 | PMID 40292035 Get It

Background Falls in people with multiple sclerosis (pwMS) lead to morbidity and expense. Objective Identify clinical metrics associated with falls. Methods Eighty-six pwMS completed fall surveys, timed 25-foot walk (T25FW), and motion analysis with Clario Opal devices. Logistic regression models were created. Results Median age was 54.5 years (range 21–73), 62% (53) were female. The cohort included 58% with relapsing (50) and 42% with progressive MS (36). Those who reported falling in the last year were older (median age 58 vs 52.5, p = .03) and had a higher Patient Determined Disease Step (PDDS) score (median 3 vs 1, p < .0001). Falls were associated with worse balance metrics including sway area (median 2.3 degrees 2 vs 1.2, p = .01), jerk (median 3.3 m 2 /s 5 vs 1.6, p = .005), and slower T25FW (median 11.5 s vs 8; p < .0001). A multivariable regression model based on gait aid use and T25FW time >10.8 s (c = 0.80) was derived. Having both features portended a probability of falling of 0.97, while having neither, a probability of 0.26. Conclusions Falls in pwMS are more frequent in patients who are older, have higher PDDS, slower walking, and worse balance. Gait aid use and T25FW >10.8 s were strongly associated with falls in the past year.
Editorial on “Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center”
Frantz, Robert P. , Frantz, Robert P

Mayo Clinic

Pulmonary Circulation | April 16, 2025 | Volume: 15 | Issue: 2 | Pages: No page available

10.1002/pul2.70081 | PMID 40241914 Get It

A Diagnostic Dilemma: Disseminated Histoplasmosis Presenting as a Small-Bowel Obstruction
Stoll, Nicolas Tapia, Saleh, Hasan , Jackson, Brittany , Baptista, Aleksandra Murawska , Oring, Justin , Durvasula, Ravi , Nakhleh, Raouf E. , Kinnucan, Jami , Kashani, Daniel , Tapia Stoll, Nicolas , Murawska Baptista, Aleksandra, Al Hashash, Jana G, Oring, Justin , Stoll, Nicolas Tapia, Hashash, Jana G.

Mayo Clinic

American Journal of Case Reports | April 15, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.946515 | PMID 40383940 Get It

To the Editor: In response to “A Perspective on Promotion in Place and Competency-Based, Time-Variable Graduate Medical Education”—Reply
Rose, Steven H., Long, Timothy R.

Mayo Clinic

Journal of Graduate Medical Education | April 15, 2025 | Volume: 17 | Issue: 2 | Pages: 244-245

10.4300/jgme-d-25-00173.1 | PMID 40417108 Get It